SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hannah Flynn, Philippa Lewis, Rational care or rationing care? The case of cervical screening across the United Kingdom, Health Policy, 2013, 112, 3, 197

    CrossRef

  2. 2
    Zaibo Li, R. Marshall Austin, Ming Guo, Chengquan Zhao, Screening Test Results Associated With Cancer Diagnoses in 287 Women With Cervical Squamous Cell Carcinoma, Archives of Pathology & Laboratory Medicine, 2012, 136, 12, 1533

    CrossRef

  3. 3
    David W. Kindelberger, Jeffrey F. Krane, Kenneth R. Lee, Diagnostic Gynecologic and Obstetric Pathology, 2011,

    CrossRef

  4. 4
    Deborah J. Chute, Harumi Lim, Christina S. Kong, BD focalpoint slide profiler performance with atypical glandular cells on SurePath Papanicolaou smears, Cancer Cytopathology, 2010, 118, 2
  5. 5
    EL Moss, P Pearmain, S Askew, G Owen, TM Reynolds, IM Prabakar, G Douce, J Parkes, V Menon, RW Todd, CWE Redman, Implementing the national invasive cervical cancer audit: a local perspective, BJOG: An International Journal of Obstetrics & Gynaecology, 2010, 117, 11
  6. 6
    Johannes Berkhof, Veerle M. Coupé, Johannes A. Bogaards, Folkert J. van Kemenade, Theo J. Helmerhorst, Peter J. Snijders, Chris J. Meijer, The health and economic effects of HPV DNA screening in The Netherlands, International Journal of Cancer, 2010, 127, 9
  7. 7
    Amanda Herbert, Gillian Holdsworth, Ali Kubba, Why young women should be screened for cervical cancer: The distinction between CIN2 and CIN3, International Journal of Cancer, 2010, 126, 9
  8. 8
    Christine Waddell, Ashish Chandra, Diagnostic Cytopathology, 2010,

    CrossRef

  9. 9
    Tino F. Schwarz, Marek Spaczynski, Achim Schneider, Jacek Wysocki, Andrzej Galaj, Pamela Perona, Sylviane Poncelet, Toufik Zahaf, Karin Hardt, Dominique Descamps, Gary Dubin, Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years, Vaccine, 2009, 27, 4, 581

    CrossRef

  10. 10
    Edesio Martins, Maria Paula Curado, Nilceana Maya Aires Freitas, José Carlos de Oliveira, Ruffo Freitas-Junior, Increase in Cervical Adenocarcinoma Rate in Goiânia, GO, Brazil, International Journal of Gynecological Cancer, 2009, 19, 4, 694

    CrossRef

  11. You have free access to this content11
    A Herbert, M Gregory, SS Gupta, N Singh, Invasive cervical cancer audit: a relative increase in interval cancers while coverage increased and incidence declined, BJOG: An International Journal of Obstetrics & Gynaecology, 2009, 116, 6
  12. You have free access to this content12
    A Herbert, M Gregory, SS Gupta, N Singh, Screen-detected invasive cervical carcinoma and its clinical significance during the introduction of organized screening, BJOG: An International Journal of Obstetrics & Gynaecology, 2009, 116, 6
  13. 13
    Peter Sasieni, Alejandra Castanon, Jack Cuzick, Screening and adenocarcinoma of the cervix, International Journal of Cancer, 2009, 125, 3
  14. 14
    David Jenkins, A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention, Gynecologic Oncology, 2008, 110, 3, S18

    CrossRef

  15. 15
    Tino F Schwarz, AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention, Expert Review of Vaccines, 2008, 7, 10, 1465

    CrossRef

  16. 16
    B. Andrae, L. Kemetli, P. Sparen, L. Silfverdal, B. Strander, W. Ryd, J. Dillner, S. Tornberg, Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in Sweden, JNCI Journal of the National Cancer Institute, 2008, 100, 9, 622

    CrossRef

  17. 17
    David C. Wilbur, Comprehensive Cytopathology, 2008,

    CrossRef

  18. 18
    Johannes Berkhof, Martine C. de Bruijne, Gilda D. Zielinski, Nicole W.J. Bulkmans, Lawrence Rozendaal, Peter J.F. Snijders, René H.M. Verheijen, Chris J.L.M. Meijer, Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis, International Journal of Cancer, 2006, 118, 7
  19. 19
    A. Herruzo, M. Carmona, F.J. Rodríguez-Escudero, F. Calero, L. Chiva, O. Falcón, S. Menjón, M. Muñoz, A. Rementería, J.R. Rodríguez, M. Usandizaga, J.A. Vidart, Cáncer invasivo de cérvix en España (1995). Encuesta de la Sociedad Española de Ginecología y Obstetricia, Progresos de Obstetricia y Ginecología, 2005, 48, 5, 247

    CrossRef

  20. 20
    Johannes Berkhof, Martine C de Bruijne, Gilda D Zielinski, Chris JLM Meijer, Natural history and screening model for high-risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands, International Journal of Cancer, 2005, 115, 2
  21. 21
    S. ANDERSSON, A.-C. HELLSTRÖM, T. ÅNGSTRÖM, U. STENDAHL, G. AUER, K.-L. WALLIN, The clinicopathologic significance of laminin-5 γ2 chain expression in cervical squamous carcinoma and adenocarcinoma, International Journal of Gynecological Cancer, 2005, 15, 6
  22. 22
    Sukeerat Ruba, Meike Schoolland, Stephen Allpress, Gregory Sterrett, Adenocarcinoma in situ of the uterine cervix , Cancer Cytopathology, 2004, 102, 5
  23. 23
    Sophia S. Wang, Mark E. Sherman, Allan Hildesheim, James V. Lacey, Susan Devesa, Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000, Cancer, 2004, 100, 5
  24. 24
    Sonia Andersson, Barbro Larson, Anders Hjerpe, Claes Silfverswärd, Jan Sällström, Erik Wilander, Eva Rylander, Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection, Acta Obstetricia et Gynecologica Scandinavica, 2003, 82, 10
  25. 25
    P Sasieni, J Adams, J Cuzick, Benefit of cervical screening at different ages: evidence from the UK audit of screening histories, British Journal of Cancer, 2003, 89, 1, 88

    CrossRef

  26. 26
    Harriet O. Smith, Luis A. Padilla, Adenocarcinoma in situ of the cervix: Sensitivity of detection by cervical smear, Cancer Cytopathology, 2002, 96, 6
  27. 27
    Ellen E. Sheets, Management of adenocarcinoma in situ, micro-invasive, and early stage adenocarcinoma of the cervix, Current Opinion in Obstetrics and Gynecology, 2002, 14, 1, 53

    CrossRef